Access

News


Nature Medicine 11, 359 (2005)
doi:10.1038/nm0405-359a

Tysabri withdrawal calls entire class into question

Emily Singer1

  1. Boston

Similar drugs may all pose a risk of infections, experts say.The future of a promising treatment for multiple sclerosis (MS) is in question after two patients takinag the drug were diagnosed with a rare neurological disorder.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Therapy Rituximab and PML risk?informed decisions needed!

Nature Reviews Rheumatology News and Views (01 Oct 2009)